The OsteoSponge was shown to act similarly to autografts but has the advantage of no complications at the harvest site or postoperative donor pain. The article includes a discussion of the strengths and limitations of bone grafts for treating osseous defects.
More Articles on Orthopedic Devices:
Expanding Orthopedics Receives Patent for Spinal Device
Cutting Edge Spine’s Spinal Fusion System Now Commercially Available
FDA Announces June Review for Metal-on-Metal Hip Implants
Bacterin’s OsteoSponge Proven Equal to Autograft
A new peer-reviewed article published in Dove Press Journal has shown that Bacterin’s OsteoSponge allograft exhibits ideal properties for bone generation.
